In the first of its kind study since the launch of AstraZeneca’s Covishield and Bharat Biotech’s Covaxin in the country, the Indian Council of Medical Research (ICMR) will conduct a survey from next week to examine the effectiveness of these vaccines in preventing progression of
Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country Ramped up stock of critical product codes required
MGM Healthcare, a super-specialty hospital in the heart of Chennai city, today announced that it has successfully conducted an emergency endoscopic transnasal orbital surgery to treat a 68-year-old female COVID-infected patient who got seriously affected with Black fungus (Mucormycosis). The patient was being treated for COVID
The appointment is in alignment with the organization’s long-term strategy to integrate digital transformation, technology and innovation as core pillars to deliver enhanced patient centric services and enable wider access. Former Advisor- Strategy and Planning at Abu Dhabi Investment Authority (ADIA) and a corporate
Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC™ (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC™ is a critical drug to treat Mucormycosis
Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Authorisation during July-September. The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among
More than 1.77 crore doses of anti-coronavirus vaccines are still available with the states and Union Territories, while seven lakh doses are in the pipeline and will be received by them within the next three days, the Union Health Ministry said on Tuesday. The Government of
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including
The National Health Authority (NHA) has signed an MoU with the Govt. of Telangana to implement Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) in the state with immediate effect. The Ayushman Bharat scheme has been integrated with the existing state scheme ‘Aarogyasri’ and
A steady decline in daily new COVID-19 cases has been observed since the last 17 days in India, the Union health ministry said on Monday. It said there has been 2.6 times increase in the number of Covid tests done in the past 15 weeks in
